Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial

Ashley Verburg*, Wilbert L. Bor, I. Tarik Küçük, José P.S. Henriques, Maarten A. Vink, Willem Peter T. Ruifrok, Jacobus Plomp, Ton A.C.M. Heestermans, Carl E. Schotborgh, Pieter J. Vlaar, Michael Magro, Sem A.O.F. Rikken, Wout W.A. van den Broek, Carlos A.G. van Mieghem, Kristoff Cornelis, Liesbeth Rosseel, Karl S. Dujardin, Bert Vandeloo, Tom Vandendriessche, Bert FerdinandeArnoud W.J. van’t Hof, Jan G.P. Tijssen, Ugo Limbruno, Raffaele De Caterina, Andrea Rubboli, Dominick J. Angiolillo, Tom Adriaenssens, Willem Dewilde, Jurrien M. ten Berg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science